Loading…
Analyse transplant outcomes in distinct epochs of follow-up – Authors' reply
Change in sign of prognostic effect plus non-overlapping confidence intervals1 should alert readers (and analysts) that the prognostic influence associated with hepatocellular carcinoma had switched from being favourable for surviving the first 3 months after liver transplantation to being a risk fa...
Saved in:
Published in: | The Lancet (British edition) 2006-06, Vol.367 (9525), p.1816-1817 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Change in sign of prognostic effect plus non-overlapping confidence intervals1 should alert readers (and analysts) that the prognostic influence associated with hepatocellular carcinoma had switched from being favourable for surviving the first 3 months after liver transplantation to being a risk factor for (metastasisrelated) mortality 3-12 months after the procedure. However, one of the main aims of our analyses was to provide clinicians with a prognostic tool that could be used at the time of transplantation to assess an individual's likely subsequent risk of mortality, thus allowing an informed decision about the possible outcomes of transplantation and the potential effects of doing transplants under different conditions (eg, with or without ABO matching). |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(06)68798-9 |